NoL Index Variations Before and After a Stellate Ganglion Block
NCT ID: NCT03317782
Last Updated: 2019-09-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
20 participants
OBSERVATIONAL
2017-10-23
2019-04-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Effectiveness of a Psychological Intervention for Fibromyalgia Supported by New Technologies
NCT07347704
Occipital Nerve Stimulation in Fibromyalgia
NCT00917176
Improving Quality of Life of Fibromyalgia Patients
NCT00715195
Effects of Physical Therapy in Pain and Posture of Fibromyalgia Patients
NCT02384603
Effectiveness of Neural Therapy in Patients With Fibromiyalgia
NCT04007172
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NoL index
The NoL/PMD-200 (Medasense Biometrics Ltd, Ramat Yishai, Israel) is a multi-parameter index (0-100) that incorporates heart rate, heart rate variability (0.15-0.4 Hz band power), plethysmograph wave amplitude, skin conductance level, number of skin conductance fluctuations (NSCF), and their time derivatives9 using a non-linear regression technique. A higher index indicates higher nociception, and an index \<20 indicates adequate analgesia.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Significant pain relief from stellate ganglion block;
* Undergoing physical therapy;
* 18 years and older.
Exclusion Criteria
* Bilateral/generalized CRPS
* Patients needing sedation for the procedure
* Inability to understand a Numeric Pain rating Scale due to cognitive dysfunction or linguistic barrier
* Movement disorder making a person unable to lie still for the duration of the evaluation period.
* Patient refusal
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maisonneuve-Rosemont Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Veronique Brulotte
Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Veronique Brulotte, MD
Role: PRINCIPAL_INVESTIGATOR
Maisonneuve-Rosemont Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maisonneuve Rosemont Hospital
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-1072
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.